Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Recommendations on the use of 18F-FDG PET in oncology 3. Taxane-based combinations as adjuvant chemotherapy of early breast cancer: a meta-analysis of randomized trials 4. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer 5. Sentinel node biopsy is important in mastectomy for ductal carcinoma in situ
Top Ten Searches
brca1 prostate-specific antigen sclc fobt egd bmi dysplasia hematologic ovarian hccYour Article Summary
See Latest ArticlesObjectively measured physical activity and sedentary time of breast cancer survivors, and associations with adiposity: Findings from NHANES (2003-2006)
Cancer Causes and Control, 11/09/09
Lynch BM et al. – This is the first study to describe the objectively assessed physical activity and sedentary time of breast cancer survivors. Increasing moderate-to-vigorous and light intensity physical activity, and decreasing sedentary time, may assist with weight management and improve other metabolic health outcomes for breast cancer survivors.
Methods- 111 women from National Health and Nutrition Examination Survey (NHANES) 2003–2004 and 2005–2006 reported history of breast cancer
- Participants wore accelerometer for 7 days
- Activity levels summarized as moderate-to-vigorous intensity (accelerometer counts/min ≥ 1,952), light intensity (counts/min 100–1,951), and sedentary time (counts/min < 100)
- Anthropometric measures taken by study staff at examination centers
- Participants spent majority of day in sedentary time (66%) or light intensity activities (33%)
- Log moderate-to-vigorous intensity physical activity negatively associated with adiposity (waist circumference &beta = -9.805 [95% CI: -15.836, -3.775]; BMI &beta = -3.576 [95% CI: -6.687, -0.464])
- Light intensity physical activity negatively associated with adiposity but fully adjusted models not statistically significance
- Sedentary time was positively associated with adiposity, but fully adjusted models not statistically significant
Today in Breast...keeping you current
Receive free subspecialty "5-minute updates" via email
Contralateral breast cancer risk in BRCA1 and BRCA2 mutation carriers
Journal of Clinical Oncology, 11/30/09
Efficacy of oral tegafur-uracil (UFT) as adjuvant therapy as compared with classical cyclophosphamide, methotrexate, and 5-fluorouracil (CMF) in early breast cancer: A pooled analysis of two randomized controlled trials (N·SAS-BC 01 trial and CUBC trial)
Breast Cancer Research and Treatment, 11/30/09
Glutathione S-transferase M1 polymorphism and breast cancer susceptibility: A meta-analysis involving 46,281 subjects
Breast Cancer Research and Treatment, 11/30/09
Sponsor
Article Search
Sponsor
Sponsor